EICHOR
● Active Not Recruiting
A Long-term Extension Study of Ustekinumab in Pediatric Participants
Condition: Crohn Disease · Colitis, Ulcerative · Arthritis, Psoriatic · Sponsor: Janssen Research & Development, LLC
About this study
The purpose of this study is to collect long-term safety data of subcutaneous (SC) ustekinumab
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (48)
| Children's Center For Digestive Healthcare, Llc | Atlanta, Georgia, United States | — |
| Mount Sinai | New York, New York, United States | — |
| Levine Childrens at Atrium Health | Charlotte, North Carolina, United States | — |
| Pediatric Specialists Of Virginia | Fairfax, Virginia, United States | — |
| STAT Research S A | Buenos Aires, Argentina | — |
| Hospital de Ninos de Cordoba | Córdoba, Argentina | — |
| Centro de Investigaciones Medicas Tucuman | San Miguel de Tucumán, Argentina | — |
| Huderf | Brussels, Belgium | — |
| Cliniques Universitaires Saint Luc | Brussels, Belgium | — |
| UZ Gent | Ghent, Belgium | — |
| UZ Brussel | Jette, Belgium | — |
| Uz Gasthuisberg | Leuven, Belgium | — |
+ 36 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05092269